6949 — Pell Bio Med Technology Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Pell Bio Med Technology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	116	708	1,106	1,136
Net Total Accounts Receivable
Net Total Receivables	10.6	6.41	7.93	4.31
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	132	725	1,127	1,158
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	250	299	267	502
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	394	1,044	1,418	1,745
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44.2	57.2	89.3	321
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	169	243	248	565
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	225	801	1,170	1,180
Total Liabilities & Shareholders' Equity	394	1,044	1,418	1,745
Total Common Shares Outstanding